Uday S Gogate is a notable inventor based in North Brunswick, NJ (US). He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of stable injectable formulations for anticancer agents. With a total of 3 patents to his name, Gogate's work has the potential to enhance the efficacy of important medications.

Latest Patents

Gogate's latest patents include innovative processes and formulations that focus on improving the stability and potency of epothilones and their analogs. One of his key inventions is a process for formulating certain epothilones for parenteral administration, which allows for controlled pH levels to enhance stability. Another significant patent is for a stable, easy-to-constitute injectable formulation of the anticancer agent BMY-25067. This formulation is derived from lyophilizing a solution containing BMY-25067, ensuring that it remains effective and safe for patient use.

Career Highlights

Uday S Gogate is associated with Bristol-Myers Squibb Company, a leading global biopharmaceutical company. His work at Bristol-Myers Squibb has allowed him to collaborate with other talented professionals in the field, contributing to advancements in cancer treatment.

Collaborations

Some of Gogate's notable coworkers include Shreeram N Agharkar and Vijay H Naringrekar. Their collaborative efforts have played a crucial role in the development of innovative pharmaceutical solutions.

Conclusion

Uday S Gogate's contributions to pharmaceutical formulations demonstrate his commitment to improving patient care through innovation. His patents reflect a deep understanding of the complexities involved in drug formulation, particularly in the context of cancer treatment.